As both methylation and amplification of ACBD3 were low in breast cancer samples compared to the level of ACBD3 upregulation, the signaling pathways project (SPP) ChIPseq database was used to find ACBD3 binding factors in normal tissue that may be important in breast cancer [51]. Here, ACBD3 is linked to breast carcinoma.